DOCSLIB.ORG

Update of Decisions of the President and Notices from the European Patent

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Update of Decisions of the President and Notices from the European Patent Amtsblatt Official Journal Journal officiel Europäisches Patentamt (EPA) Sonderausgabe 3 ı 2007 European Patent Offi ce (EPO) Das revidierte Europäische Patentübereinkommen (EPÜ 2000) Offi ce européen des brevets (OEB) Neufassung von für die Praxis wichtigen Beschlüssen des Munich The Hague Vienna Präsidenten und Mitteilungen des Europäischen Patentamts Headquarters Patentlaan 2 Rennweg 12 Special edition 3 ı 2007 Erhardtstr. 27 2288 EE Rijswijk 1030 Vienna Revision of the European Patent Convention (EPC 2000) 80469 Munich Netherlands Austria Germany Tel. +31 (0)70 340-2040 Tel. +43 (0)1 52126-0 Update of decisions of the President and notices from the Tel. +49 (0)89 2399-0 Fax +31 (0)70 340-3016 Fax +43 (0)1 52126-3591 European Patent Office of relevance to patent practitioners Fax +49 (0)89 2399-4560 Postal address Postal address Edition spéciale 3 ı 2007 Postal address Postbus 5818 Postfach 90 80298 Munich 2280 HV Rijswijk 1031 Vienna Convention sur le brevet européen révisée (CBE 2000) Germany Netherlands Austria Nouveaux textes des décisions du Président et des communiqués de l’Office européen des brevets importants pour les praticiens Berlin Brussels Bureau Gitschiner Str. 103 Avenue de Cortenbergh, 60 10969 Berlin 1000 Brussels Germany Belgium Tel. +49 (0)30 25901-0 Tel. +32 (0)2 27415-90 Fax +49 (0)30 25901-840 Fax +32 (0)2 20159-28 Postal address 10958 Berlin Germany www.epo.org ISSN 0170/9291 Amtsblatt des Offi cial Journal Journal offi ciel de Europäischen of the European l’Offi ce européen Patentamts Patent Offi ce des brevets Herausgeber und Schriftleitung Published and edited by Publication et rédaction Europäisches Patentamt European Patent Offi ce Offi ce européen des brevets Direktion 5.2.2 Directorate 5.2.2 Direction 5.2.2 80298 München 80298 Munich 80298 Munich Deutschland Germany Allemagne Tel. +49 (0)89 2399-5225 Tel. +49 (0)89 2399-5225 Tél. +49 (0)89 2399-5225 Fax +49 (0)89 2399-5298 Fax +49 (0)89 2399-5298 Fax +49 (0)89 2399-5298 offi [email protected] offi [email protected] offi [email protected] Für den Inhalt verantwortlich Responsible for the content Responsable de la rédaction Direktion 5.2.2 Directorate 5.2.2 Direction 5.2.2 © EPA © EPO © OEB Bestellungen sind zu richten an: Please send your order to: Les commandes doivent être Europäisches Patentamt European Patent Offi ce adressées à : Dienststelle Wien Vienna sub-offi ce Offi ce européen des brevets Postfach 90 Postfach 90 Agence de Vienne 1031 Wien 1031 Vienna Postfach 90 Österreich Austria 1031 Vienne Tel. +43 (0)1 52126-411 Tel. +43 (0)1 52126-411 Autriche Fax +43 (0)1 52126-2495 Fax +43 (0)1 52126-2495 Tél. +43 (0)1 52126-411 [email protected] [email protected] Fax +43 (0)1 52126-2495 [email protected] Druck Printer Impression Imprimerie Centrale S.A. Imprimerie Centrale S.A. Imprimerie Centrale S.A. 1024 Luxemburg 1024 Luxembourg 1024 Luxembourg Luxemburg Luxembourg Luxembourg 2007 Sonderausgabe Nr. 3 ABl. EPA / Special edition No. 3 OJ EPO / Edition spéciale n° 3 JO OEB I Inhalt Contents Sommaire Das revidierte Europäische Revision of the European Convention sur le brevet Patentübereinkommen Patent Convention européen révisée (EPÜ 2000) (EPC 2000) (CBE 2000) Neufassung von für die Update of decisions of the Nouveaux textes des Praxis wichtigen Beschlüs- President and notices from décisions du Président et sen des Präsidenten und the European Patent Office des communiqués de Mitteilungen des Euro- of relevance to patent l'Office européen des päischen Patentamts practitioners brevets importants pour les praticiens Vorwort 1 Preface 1 Introduction 1 A. Einreichung von europäischen A. Filing of European patent A. Dépôt de demandes de brevet Patentanmeldungen und anderen applications and other documents européen et d'autres pièces Unterlagen 1. Beschluss der Präsidentin des Euro- 1. Decision of the President of the 1. Décision de la Présidente de l'Office päischen Patentamts vom 12. Juli 2007 European Patent Office dated 12 July européen des brevets, en date du 12 juil- über die Bestimmung der Annahmestel- 2007 concerning the designation of the let 2007, relative à la désignation des len des EPA 3 EPO filing offices 3 bureaux de réception de l'OEB 3 2. Mitteilung des Europäischen Patent- 2. Notice from the European Patent 2. Communiqué de l'Office européen amts vom 12. Juli 2007 über die Erreich- Office dated 12 July 2007 concerning des brevets, en date du 12 juillet 2007, barkeit der Annahmestellen des EPA the availability of the EPO filing relatif à l'accessibilité des bureaux de 5 offices 5 réception de l'OEB 5 3. Beschluss der Präsidentin des Euro- 3. Decision of the President of the 3. Décision de la Présidente de l'Office päischen Patentamts vom 12. Juli 2007 European Patent Office dated 12 July européen des brevets, en date du über die Einreichung von Patentanmel- 2007 concerning the filing of patent 12 juillet 2007, relative au dépôt de dungen und anderen Unterlagen durch applications and other documents by demandes de brevet et d'autres pièces Telefax 7 facsimile 7 par téléfax 7 4. Beschluss der Präsidentin des Euro- 4. Decision of the President of the 4. Décision de la Présidente de l'Office päischen Patentamts vom 12. Juli 2007 European Patent Office dated 12 July européen des brevets, en date du über die elektronische Einreichung von 2007 concerning the electronic filing 12 juillet 2007, relative au dépôt électro- Patentanmeldungen und anderen of patent applications and other nique de demandes de brevet et d'autres Unterlagen 12 documents 12 pièces 12 5. Beschluss der Präsidentin des Euro- 5. Decision of the President of the 5. Décision de la Présidente de l'Office päischen Patentamts vom 12. Juli 2007 European Patent Office dated 12 July européen des brevets, en date du über die zu benutzenden elektronischen 2007 concerning the electronic signa- 12 juillet 2007, relative aux signatures et Signaturen, Datenträger und Software tures, data carriers and software to be supports de données électroniques ainsi zur elektronischen Einreichung von used for the electronic filing of patent qu'aux logiciels à utiliser pour le dépôt Patentanmeldungen und anderen applications and other documents 17 électronique de demandes de brevet et Unterlagen 17 d'autres pièces 17 6. Mitteilung des Europäischen Patent- 6. Notice from the European Patent 6. Communiqué de l'Office européen amts vom 12. Juli 2007 über die elektro- Office dated 12 July 2007 concerning des brevets, en date du 12 juillet 2007, nische Einreichung von europäischen theelectronicfilingofEuropeanpatent relatif au dépôt électronique de deman- Patentanmeldungen beim Deutschen applications with the German Patent and des de brevet européen auprès de Patent- und Markenamt (DPMA) 19 Trade Mark Office (DPMA) 19 l'Office allemand des brevets et des marques (DPMA) 19 II Sonderausgabe Nr. 3 ABl. EPA / Special edition No. 3 OJ EPO / Edition spéciale n° 3 JO OEB 2007 B. Prioritätsunterlagen B. Priority documents B. Documents de priorité 1. Beschluss der Präsidentin des Euro- 1. Decision of the President of the 1. Décision de la Présidente de l'Office päischen Patentamts vom 12. Juli 2007 European Patent Office dated 12 July européen des brevets, en date du über die Einreichung von Prioritätsunter- 2007 on the filing of priority 12 juillet 2007, relative à la production lagen 22 documents 22 de documents de priorité 22 2. Beschluss der Präsidentin des Euro- 2. Decision of the President of the 2. Décision de la Présidente de l'Office päischen Patentamts vom 12. Juli 2007 European Patent Office dated 12 July européen des brevets, en date du über die Einreichung von Prioritätsunter- 2007 concerning the filing of priority 12 juillet 2007, relative à la production lagen bei europäischen Teilanmeldun- documents for European divisional de documents de priorité dans le cas de gen und neuen europäischen Patent- applications and for new European demandes divisionnaires européennes anmeldungen nach Artikel 61 (1) b) EPÜ patent applications under Article 61(1)(b) et de nouvelles demandes de brevet 24 EPC 24 européen déposées en application de l'article 61(1)b) CBE 24 C. Biotechnologische Erfindungen C. Biotechnological inventions C. Inventions biotechnologiques 1. Beschluss der Präsidentin des Euro- 1. Decision of the President of the 1. Décision de la Présidente de l'Office päischen Patentamts vom 12. Juli 2007 European Patent Office dated 12 July européen des brevets, en date du über die Einreichung von Sequenz- 2007 concerning the filing of sequence 12 juillet 2007, relative au dépôt de protokollen 26 listings 26 listages des séquences 26 1.1 Anhang zum Beschluss der Präsi- 1.1 Annex to the Decision of the Presi- 1.1 Annexe à la décision de la Prési- dentin des Europäischen Patentamts dent of the European Patent Office dated dente de l'Office européen des brevets, vom 12. Juli 2007 über die Einreichung 12 July 2007 concerning the filing of en date du 12 juillet 2007, relative au von Sequenzprotokollen 29 sequence listings 29 dépôt de listages des séquences 29 1.1.1 WIPO-Standard ST. 25 1.1.1 WIPO STANDARD ST. 25 1.1.1 Norme ST. 25 de l'OMPI Standard für die Darstellung von Nucleo- Standard for the presentation of nucleo- Norme relative à la présentation du tid- und Aminosäuresequenzprotokollen tide and amino acid sequence listings in listage des séquences de nucléotides et in Patentanmeldungen 29 patent applications 29 d'acides aminés dans les demandes de brevet 29 1.1.2 Anhang C 1.1.2 Annex C 1.1.2 Annexe C Standard für die Darstellung von Nucleo- Standard for the presentation of nucleo- Norme relative à la présentation du tid- und Aminosäuresequenzprotokollen tide and amino acid sequence listings in listage des séquences de nucléotides et in internationalen Patentanmeldungen international patent applications under d'acides aminés dans les demandes nach dem PCT 30 the PCT 30 internationales de brevet déposées selon le PCT 30 2.
Load more

Recommended publications
  • The European Patent Convention and the London Agreement
    Feature European changes The European Patent Convention and the London Agreement EPC 2000 – why change? By Pierre-André Dubois and Shannon The EPC 1973 came into force in 1977 and Yavorsky, Kirkland & Ellis International LLP revolutionised patent practice. However, in the last 30 years, the patent landscape The European Patent Convention (EPC 2000) changed significantly and it became apparent came into force on 13th December 2007, that there was a real need to overhaul the introducing sweeping changes to the dated legislation. First, the Agreement on European patent system. The new Trade Related Aspects of Intellectual convention governs the granting of European Property Rights (TRIPs) and the Patent Law patents by the European Patent Office (EPO) Treaty (PLT) came into force, and it was and applies throughout the 34 contracting questionable whether the EPC 1973 was in states of the European Patent Organisation line with the provisions of each of these (ie, the 27 EU Member States as well as agreements. As one example, the EPC 2000 Croatia, Iceland, Liechtenstein, Monaco, clarifies that, in accordance with TRIPs, Norway, Switzerland and Turkey). The original patents can now be granted in all fields of convention (EPC 1973), which dates back to technology as long as they are new, 1973, was outdated due to a number of comprise an inventive step and are developments in international law and the susceptible of industrial application. Second, need to improve the procedure before the the EPC 1973 was difficult to amend and, in EPO. While the new convention does not the face of fast-changing technology and overhaul substantive patent law (ie, what European legislation, required greater is patentable and what is not), it does legislative flexibility.
    [Show full text]
  • Working Guidelines Q238 Second Medical Use and Other Second
    Working Guidelines by Thierry CALAME, Reporter General Sarah MATHESON and John OSHA, Deputy Reporters General Anne Marie VERSCHUR, Sara ULFSDOTTER and Kazuhiko YOSHIDA Assistants to the Reporter General Q238 Second medical use and other second indication claims Introduction 1) This question seeks to determine the type, scope and enforcement of patent protection for new uses of known chemical compounds when a known substance is found to have a new therapeutic use. For convenience, these guidelines will refer to such use as 'second medical use'. Various types of second medical use are described below. 2) The granting of patent protection for second medical uses potentially provides an important incentive for the identification and development of solutions for unmet medical needs. Second medical use patents can also be a major tool of the originator pharmaceutical industry as part of patent lifecycle management. However, the additional research and development work is time- consuming and expensive. Patent protection is important, but sufficient incentive to encourage research into second medical uses lies in the potential availability of enforceable patent rights of effective scope. 3) Currently, whether patent protection for second medical uses is permitted at all, and if so, the form of permissible claims, varies from country to country. The ability to enforce permissible claims, and the scope of protection afforded, also varies between jurisdictions. Lack of harmonisation impacts both originator and generic pharmaceutical companies by creating uncertainty both for patent holders and assumed infringers. 4) The granting of patent protection for second medical uses gives rise to competing positive and negative impacts on the provision of effective medicines to the public.
    [Show full text]
  • Patent-Related Barriers to Market Entry for Generic Medicines in the European Union
    atents play an important role in modern society. In order to encourage the creation, dissemination and efficient P exploitation of technology, patents provide inventors Patent-related Barriers with a limited term legal monopoly on their invention. Generic medicines play an equally important role in promoting to Market Entry for pharmaceutical innovation and ensuring the affordability and sustainability of European healthcare systems. In this regard, Generic Medicines in immediate market access of generic medicines after patent expiry is of crucial interest to society, and any hurdle to this the European Union access should be eliminated. However, a number of developments point to a strategic use of patents—of sometimes questionable quality—which is directed more toward preventing others from innovating and competing, A Review of Weaknesses in the Current than toward creating truly innovative products. When misused European Patent System and their Impact in this manner, patents can present a barrier to entry onto the on the Market Access of Generic Medicines generic medicines market. This report identifies some of the hurdles that generic medicines companies face in this regard in the European Union. Editor Kristof Roox | Attorney at the Brussels Bar | Belgium European Patent Office Headquarters | Munich, Germany EUROPEAN GENERIC MEDICINES ASSOCIATION EUROPEAN GENERIC Rue d’Arlon 50 B-1000 Brussels | Belgium MEDICINES ASSOCIATION Tel: +32 (0) 2 736 84 11 | Fax: +32 (0) 2 736 74 38 www.egagenerics.com | [email protected] Layout & Design:
    [Show full text]
  • EUROPEAN PATENT OFFICE Guidelines for Examination General Part Amended in December, 2007
    EUROPEAN PATENT OFFICE Guidelines for Examination General Part Amended in December, 2007 CONTENTS 1. Preliminary remarks 2. Explanatory notes 2.1 Overview 2.2 Abbreviations 3. General remarks 4. Work at the EPO 5. Survey of the processing of applications and patents at the EPO 6. Contracting States to the EPC 7. Extension to states not party to the EPC 1 1. Preliminary remarks In accordance with Art. 10(2)(a) of the European Patent Convention (EPC), the President of the European Patent Office (EPO) had adopted, effective as at 1 June 1978, the Guidelines for Examination in the European Patent Office. These Guidelines have been and will be updated at regular intervals to take account of developments in European patent law and practice. Amended or new text (as compared to the latest previous version only) is indicated by a vertical line in the right-hand margin. Mere deletions are indicated by two horizontal lines in the right-hand margin. Usually, updates only involve amendments to specific sentences or passages on individual pages, in order to bring at least part of the text more closely into line with patent law and EPO practice as these continue to evolve. It follows that no update can ever claim to be complete. Any indication from readers drawing the attention to errors as well as suggestions for improvement are highly appreciated and may be sent by e-mail to: [email protected] The Guidelines for Examination in the European Patent Office are also published by the EPO in an electronic, searchable form on the Internet via the EPO website: http://www.epo.org 2.
    [Show full text]
  • Guidelines for Examination in the European Patent Office
    GUIDELINES FOR EXAMINATION IN THE EUROPEAN PATENT OFFICE Published by the European Patent Office Published by the European Patent Office Directorate Patent Law 5.2.1 D-80298 Munich Tel.: (+49-89) 2399-4512 Fax: (+49-89) 2399-4465 Printed by: European Patent Office, Munich Printed in Germany © European Patent Office ISBN 3-89605-074-5 a LIST OF CONTENTS page General Part Contents a 1. Preliminary remarks 1 2. Explanatory notes 1 2.1 Overview 1 2.2 Abbreviations 2 3. General remarks 3 4. Work at the EPO 3 5. Survey of the processing of applications and patents at the EPO 4 6. Contracting States to the EPC 5 7. Extension to states not party to the EPC 5 Part A – Guidelines for Formalities Examination Contents a Chapter I Introduction I-1 Chapter II Filing of applications and examination on filing II-1 Chapter III Examination of formal requirements III-1 – Annex List of Contracting States to the Paris Convention (see III, 6.2) III-20 Chapter IV Special provisions IV-1 Chapter V Communicating the formalities report; amendment of application; correction of errors V-1 Chapter VI Publication of application; request for examination and transmission of the dossier to Examining Division VI-1 Chapter VII Applications under the Patent Cooperation Treaty (PCT) before the EPO acting as a designated or elected Office VII-1 Chapter VIII Languages VIII-1 Chapter IX Common provisions IX-1 Chapter X Drawings X-1 Chapter XI Fees XI-1 Chapter XII Inspection of files; communication of information contained in files; consultation of the Register of European
    [Show full text]
  • World Intellectual Property Organization Geneva
    E WIPO SCIT/ATR/PI/1999/EP WORLD INTELLECTUAL PROPERTY ORGANIZATION GENEVA STANDING COMMITTEE ON INFORMATION TECHNOLOGIES ANNUAL TECHNICAL REPORT 1999 ON PATENT INFORMATION ACTIVITIES* submitted by the EUROPEAN PATENT OFFICE An annual series of reports on the patent information activities of members of the Standing Committee on Information Technologies * – The term “patent” covers utility models and SPCs. – Information related to design patent activities reported by industrial property offices issuing design patents is included in the series of documents SCIT/ATR/ID. European Patent Office Technical Report on Patent Information Activities in 1999 European Patent Office 29 May 2000 Technical Report on Patent Information Activities in 1999 Page II Table of Contents I. EVOLUTION OF PATENT ACTIVITIES ........................................................................... 1 II. MATTERS CONCERNING GENERATION, REPRODUCTION, DISTRIBUTION AND USE OF PRIMARY AND SECONDARY SOURCES OF PATENT INFORMATION....... 2 1. Printing and Publication of Patent Documents........................................................... 2 1.1 Patent Applications ............................................................................................ 2 1.2 Granted Patents................................................................................................. 3 2. Main Types of Announcements in the Field of Patent Information ............................ 4 3. Publication Media.......................................................................................................
    [Show full text]
  • The European Patent Office
    INTEllECTUAl PROPERTY 286 CHIMIA 2000, 54, No.5 Chimia 54 (2000) 286-287 © Neue Schweizerische Chemische Gesellschatl ISSN 0009-4293 Safeguarding Europe-Wide Patent Protection: the European Patent Office Ulrich Schatz* Abstract: The European patent system, created in 1977, provides for the co-existence of a national and a centralised procedure for the grant of patents. Central grant authority for European patents is the European Patent Office in Munich, which carries out its task on the basis of the provisions laid down in the European Patent Convention. The establishment of a Europe-wide patent system has led to a significant increase in the demand for patent rights in Europe. Inthe framework of their co-operation, the member states of the European Patent Organisation have also created a unique patent information network for accessing the information contained in patent documents. In view of its impending eastward expansion, the European Patent Organisa- tion is set to undertake a revision of the European patent system to ensure its flexibility in the future. Keywords: esp@cenet . Europe· Innovation· Internet· Patent information' Patents The conclusion of the European Patent borders proves that this Organisation has grounds for revocation by the EPO in an Convention on 5 October 1973 was an changed the landscape of industrial prop- opposition procedure and those by na- important milestone on the road to a uni- erty protection in Europe. The worldwide tional courts in revocation or infringe- fied patent in Europe. In 1997 the Europe- development in the field of patents has, ment procedures. Furthermore, the Con- an Patent Office celebrated its 20th anni- moreover, been significantly influenced vention provides for professional repre- versary, The founding of the European by the European Patent Convention enter- sentation before the EPO, creates the Patent Organisation in 1977 and the open- ing into force.
    [Show full text]
  • Examination Guidelines for Patent Applications Relating to Medical Inventions in the Intellectual Property Office
    Examination Guidelines for Patent Applications relating to Medical Inventions in the Intellectual Property Office April 2016 © Crown copyright 2016 Intellectual Property Office is an operating name of the Patent Office April 2016 3 Contents Introduction ......................................................................................................................paragraphs 1-5 Basic principles .............................................................................................................paragraphs 6-10 Methods of treatment or diagnosis ...........................................................................paragraphs 11-15 Therapy Definition of “therapy” ....................................................................................................paragraphs 16-17 Therapeutic methods: form of claims ............................................................................paragraphs 18-19 Guidelines for determining whether a method is “treatment by therapy” .....................paragraphs 20-22 Claims to both therapeutic and non-therapeutic methods ...........................................paragraphs 23-28 Therapeutic and non-therapeutic methods: specific examples i) Cosmetic treatments ................................................................................................. paragraph 29 ii) Removal of parasites .........................................................................................paragraphs 30-31 iii) Oral care .................................................................................................................
    [Show full text]
  • PCT Newsletter 07-08/2021 (July-August 2021)
    www.wipo.int/pct/en July-August 2021 | No. 07-08/2021 Filing and Processing of International Applications in Electronic Form Ceasing of development, distribution and support for the PCT-SAFE software by the International Bureau As from 30 June 2022, the International Bureau (IB) will end its development, distribution and support of the PCT-SAFE software; the final scheduled release will be in April 2022, and no further updates to the software will be provided after that date. It is recalled that since 1 July 2021, the International Bureau as receiving Office (RO) has no longer been accepting international applications filed in electronic form using the PCT-SAFE software. It is expected that the few remaining ROs that currently accept PCT-SAFE filings will notify the IB that they will no longer accept PCT-SAFE filings after 30 June 2022. Any remaining PCT-SAFE users are strongly advised to transition to ePCT-Filing as soon as possible, if accepted by their competent RO1. For the list of ROs which accept ePCT-Filings (currently 72 Offices2), please refer to: https://pct.wipo.int/ePCTExternal/pages/EFilingServers.xhtml The IB strongly advises applicants, as from 1 July 2022, not to prepare and file PCT applications using any existing versions of the PCT-SAFE software, even if an RO has not yet formally notified the IB by that date that it will no longer accept PCT-SAFE filings. Filers who use PCT-SAFE as from 1 July 2022 will do so at their own risk. Very few applicants still file their international applications using PCT-SAFE, as the majority have already switched to using ePCT-Filing in order to benefit from its many safeguards and other advantages.
    [Show full text]
  • Table of Contents
    Information 4/2000 117 Table of contents Editorial .................... 118 Oral proceedings and training therefor at the EPO in practice, by E. Krause (EPO) .... 150 How to satisfy trainingdemands I ± Information concerning epi by the Professional Qualifications Committee of epi, by S. Kaminski (epi)......151 Practical experiences of European Patent Council Meeting Attorneys in industry and private practice, by T. Onn (epi)..................154 Bericht über die 49. Ratssitzung, Rhodos, The oral hearingwithin education and 23. Oktober 2000 ............... 119 professional practice of the German Patent Entwurf der Beschlussliste............ 120 Attorney, by H. Lichti (PAK) ........... 155 Report of the 49th Council meeting, Rhodes, Further developments toward representation 23 October 2000 ................ 121 before courts ± Zehn Gründe für eine Draft List of Decisions.............. 122 Vertretungsbefugnis der Patentanwälte Compte rendu de la 49me rØunion du Conseil, in Europa vor einem künftigen Europäischen Rhodes, 23 octobre 2000 ............ 123 Patentgericht, by U. Dreiss (PAK)......... 158 Projet de Liste des DØcisions. .......... 124 President©s report ................ 125 Report on the 2nd Intergovernmental epi Membership / epi Subscription ...... 163 Conference on Reform of the EPO, by W. Holzer 126 Abschiedsworte an Herrn F. Jenny........ 131 Treasurer©s report ................ 132 Information from the Secretariat Deadline 1/2001................. 171 Committee Reports Queen Mary College Training Course ...... 186 epi Membership chart as of 31.10. 2000..... 187 Report of the EASY Committee, by D. Speiser . 132 epi Disciplinary bodies and Committees ..... 188 Report of the EPO Finances Committee, epi Board.................... U3 by J. Boff .................... 134 Report of the European Patent Praxis Committee (EPPC), II ± Contributions from epi-Members and other by A. Casalonga ................ 135 contributions Report of the epi Finance Committee, by B.
    [Show full text]
  • Supreme Court of the United States ------ ------SEQUENOM, INC., Petitioner, V
    No. 15-1182 ================================================================ In The Supreme Court of the United States --------------------------------- --------------------------------- SEQUENOM, INC., Petitioner, v. ARIOSA DIAGNOSTICS, INC., et al., Respondents. --------------------------------- --------------------------------- On Petition For A Writ Of Certiorari To The United States Court Of Appeals For The Federal Circuit --------------------------------- --------------------------------- BRIEF OF PROFESSOR TIMO MINSSEN AND ROBERT M. SCHWARTZ WITH 10 EUROPEAN AND AUSTRALIAN LAW PROFESSORS AS AMICI CURIAE IN SUPPORT OF PETITIONER --------------------------------- --------------------------------- ANDREW J. DHUEY Counsel of Record 456 Boynton Avenue Berkeley, CA 94707 (510) 528-8200 [email protected] Counsel for Amici Curiae TIMO MINSSEN Professor of Biotechnology Law (fr. 1 May 2016) FACULTY OF LAW UNIVERSITY OF COPENHAGEN Studiestraede 6 DK-1455 Copenhagen K, Denmark ROBERT M. SCHWARTZ Researcher FACULTY OF LAW LUND UNIVERSITY Lilla Gråbrödersgatan 4 222 22 Lund, Sweden ================================================================ COCKLE LEGAL BRIEFS (800) 225-6964 WWW.COCKLELEGALBRIEFS.COM i TABLE OF CONTENTS Page TABLE OF AUTHORITIES ................................... ii INTEREST OF THE AMICI CURIAE ................... 1 SUMMARY OF ARGUMENT ................................ 2 ARGUMENT ........................................................... 3 I. The European legal framework for patent eligibility .....................................................
    [Show full text]
  • Epoline Newsletter 2/99
    European Patent Office Newsletter epoline® Newsletter Number 2 As a user of EASY, EPA/EPA/OEB Form, PatentIn or the Register of European Patents, you will automatically receive our epoline® Newsletter. If you would prefer to be removed from our list, please see the instructions at the end of this message. ______________________________________________________________________________________ communication for the various transactions available. ® The internal systems will be connected together so epoline that they act as a single point of contact. ® Further details of the project and its progress will be What is epoline ? provided in future issues of the newsletter. In recent years, the EPO has invested in the Please also visit the epoline® web site for further automation of various areas of the Patent Granting background.: http://www.epoline.org procedure in order to improve the efficiency of these areas (e.g. CAESAR for Search Report How to contact the epoline® Help preparation and PHOENIX for the elimination of Desk paper dossiers). These disparate developments have produced operational systems but their Please contact us as follows: effectiveness has remained internal to the EPO. All e-mail: [email protected] interactions with the “outside” world have continued to involve the receipt and production of Fax: + 31 70 340 4600 paper documents so that, from the perspective of Tel.: + 31 70 340 4500 Mail: the EPO’s clients, there are no tangible advantages ® and no participation in the electronic processes. epoline Help Desk European Patent Office However, the extraordinary advances in Internet Patentlaan 2 and related technologies now make it possible for NL - 2288 EE RIJSWIJK (Z-H) even the smallest enterprises to conduct business The Netherlands transactions completely electronically with all the attendant benefits of ease of use, security, instant ® acknowledgement and, of course, lower costs.
    [Show full text]